Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
SS&C Technologies is turning steady recurring software revenue and sizable free cash flow into a compounding acquisition engine. At roughly $18.5B market cap and $1.75B in free cash flow, management can both pay down debt and bolt on software franchises that expand margins and sticky revenue. This trade targets a re-rating toward a mid-20s P/E over…
OneMedNet Corporation will execute a 1-for-10 reverse stock split effective September 29, 2026, approved by shareholders to comply with Nasdaq Capital Market's minimum bid price rules and to potentially broaden investor interest. The reverse split reduces outstanding shares from approximately 59.3 million to about 5.9 million, with proportional adj…
Domino's Pizza Group (DOM) is my preferred way to play the global Domino's brand over the larger U.S. parent. The U.K. business combines a lightweight capital model, steady unit economics, and clearer near-term catalysts — making it a pragmatic mid-term trade. I lay out an entry, stop and target with a 45 trading day horizon and a balanced risk fra…
Meta's Muse AI agent has already moved the needle on sentiment and user engagement. The market is treating Muse like a subscription experiment; we argue its advertising signal capture and higher CPM potential are worth far more. Trade idea: buy META at $750.60 with a $900 target and $690 stop for a long-term position (180 trading days).
XPeng trades near its 52-week low with a $9.7B market cap despite clear traction in deliveries, rising NEV penetration, and a growing software and robotics roadmap. This trade targets the company's robotics and robotaxi optionality as the asymmetric upside while using EV and ADAS execution as the nearer-term value support. Entry, stop, and target a…
SELLAS Life Sciences (SLS) is a small clinical-stage oncology shop trading at $11.66 after a pullback tied to a regulatory/investor probe story. The setup is a swing trade: buy the dip into improving technical support, leverage an elevated short-interest backdrop and upcoming potential readouts, while sizing for binary clinical and legal risk. Entr…
Pinnacle Acquisition Corporation announced that starting September 25, 2026, investors will be able to trade the company's Class A ordinary shares and rights separately, following their initial trading as units in the IPO. The shares and rights will trade under the symbols 'PNAQ' and 'PNAQ.RT' respectively on the New York Stock Exchange. Pinnacle A…
Oracle has been accused of being slow to the cloud and AI party, but its underlying cash generation, sticky enterprise contracts, accelerating OCI traction, and aggressive capital return make short-term execution noise a buying opportunity. This trade idea lays out a clear entry, stop, and target for a 180-trading-day campaign to capture a valuatio…
AMD has been through multiple inflection points: server share gains with EPYC, GPU expansion for data center workloads, and continued strength in client processors. After a period of consolidation, the next material leg higher looks like it will be driven by another enterprise AI ramp and product cadence in 2026. This trade idea offers an actionabl…
ChangeNOW has published its TOKEN2049 Singapore schedule, centering on a booth that blends retrofuturism and Japanese Metabolism, a Fast Track Program to onboard early-stage wallets, a limited CoolWallet co-branded hardware run, and a series of talks and partner events on October 6-8. The company will host a central podcast studio, PR and partner s…
Pharming Group announced that the U.S. FDA has accepted for Priority Review its supplemental New Drug Application seeking approval for lower doses of Joenja® (leniolisib) to treat children aged 4 years and older weighing between 13 kg and 27 kg with activated phosphoinositide 3-kinase delta syndrome (APDS). The FDA's target action date is January 3…
Greenland Mines Ltd, a Nasdaq-listed mineral resource company focused on critical metals in Greenland, announced its shares are now listed on the Frankfurt Stock Exchange under ticker HK6. This dual listing enhances access for European investors and supports the company's strategy to build a transatlantic critical minerals supply chain linking Gree…
Starbucks has checked the boxes on digital and daypart execution, posted consecutive comp growth, and sits on solid cash flows. Valuation is rich but technicals show oversold conditions and catalysts — from a near-complete digital menu rollout to upcoming results — make a mid-term long trade attractive. Upgrade to BUY for a mid-term (45 trading day…
Five9's core contact-center business is generating meaningful free cash flow and the stock has recovered from its spring lows as AI conversations push re-rating. The fundamentals support a mid-term long trade: entry $36.50, stop $32.00, target $44.00 over ~45 trading days, with a clear plan for when to reassess.
Old National Bancorp, a major Midwest-based commercial bank, announced that it will release its third-quarter earnings on October 21, 2026, followed by a conference call for investors. The company holds significant assets and continues its focus on community engagement and comprehensive financial services.
Credo (CRDO) just launched 224G ZeroFlap optics and is guiding for very large optical revenue potential in fiscal 2027. The stock’s current pullback offers a tactical long with clear upside to the recent 52-week high if execution and hyperscaler ramps proceed. Valuation is rich, so position sizing and a strict stop are essential.
Atlassian's recent operational momentum - double-digit cloud growth, record large deals and a rising ARR - has the stock trading near its 52-week high. Fundamentals point to durable growth, but at a market cap near $48.7B and a price-to-sales of 7.4 the stock is no longer a cheap bet. This trade idea recommends a measured long with a clear stop and…
I sold Uber in March after a run-up. The stock has pulled back into the high-$60s, trading at roughly 14.8x trailing earnings with $9.44B in free cash flow and a $141B market cap. That combination of profitability, cash generation and a manageable capital structure justifies re-entering on a long-term trade plan. This note explains the thesis, valu…
U.S. Trade Representative Jamieson Greer said details of recent negotiations with China will be released on Monday, describing progress and managed trade arrangements that include agreed exemptions for particular goods. While agricultural products, medical devices and certain non-sensitive consumer items are part of the exchange, high-end U.S.-made…
Tencent combines scale in games, social and payments with accelerating AI adoption across content, cloud and ad products. At $55.80 the shares trade at a P/E of 15.1 with a $507.5B market cap. This trade targets a bounce toward $68 over a mid-term horizon (45 trading days) while protecting capital near the 52-week low.
AstraZeneca (AZN) trades below its 52-week high but shows improving earnings momentum, a diversified oncology-heavy pipeline and stable free cash flow. Valuation is reasonable relative to growth runway; a disciplined long with a $155 stop and $190 target balances upside and headline risks over a multi-month position.
Banco Santander Chile announces its third quarter 2026 conference call and webcast scheduled for November 4, 2026, to discuss financial results and provide management commentary. The bank highlights its recent financial standing as of June 30, 2026, including total assets, loans, deposits, equity, and capital ratios, reaffirming its strong credit r…
Integra LifeSciences highlights two decades of its CUSA® Ultrasonic Surgical Aspirator technology during the American College of Surgeons Clinical Congress 2026. The company features surgeon-led programs focusing on liver surgery advancements and education, showcasing their innovative surgical instruments to support complex hepatobiliary treatments…
SBC Medical Group Holdings, a Nasdaq-listed Medical Services Organization, announced its participation in several notable investor conferences in October 2026, aiming to engage institutional investors and present its growth strategies. The company continues to expand its global footprint in various healthcare specialties and maintain its position i…
INVO Fertility, a healthcare company specializing in fertility clinics and related technologies, will participate in the Lytham Partners Fall 2026 Investor Conference with a webcast presentation and one-on-one investor meetings. The company focuses on expanding access to assisted reproductive technologies through clinic operations and proprietary m…
